Caplin Point Laboratories Ltd - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 201514-08-2021
14-08-2021
Buy Caplin Point Laboratories; target of Rs 1135: ICICI Direct
ICICI Direct is bullish on Caplin Point Laboratories has recommended buy rating on the stock with a target price of Rs 1135 in its research report dated August 07, 2021.10-08-2021
Earnings Call for Q1FY22 of Caplin Point Laboratories
Conference Call with Caplin Point Laboratories Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.06-08-2021
Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Dividend Updates
Recommended a Final Dividend of Rs. 1.50/- (75 %) per equity share of Rs.2 each for the financial year ended 31st March 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting.05-08-2021
Caplin Point Laboratories Ltd - 524742 - Approved The Un-Audited Standalone And Consolidated Financial Results And The Limited Review Report Of The Company As Per Indian Accounting Standards For The Quarter Ending 30Th June, 2021.
Approved the Un-audited standalone and consolidated financial results and the Limited Review Report of the Company as per Indian Accounting Standards for the quarter ending 30th June, 2021.05-08-2021
CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting05-08-2021
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that a conference call with the analysts/ fund houses post results will be held on Friday, 6th August 2021 at 3.30 P.M. {1ST) to discuss the financial performance of the Company for the quarter ended 30th June 2021. A copy of the Conference Call Invitation is enclosed for your reference.04-08-2021
CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results For The Quarter Ended 30Th June 2021 And Recommendation Of Final Dividend For The FY 2020-21.
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2021 ,inter alia, to consider and approve i) the quarterly un-audited financial results of the Company for the quarter ended 30th June 2021 (both standalone & consolidated) and ii) recommendation of Final Dividend, for the FY 2020-21 and fixation of record date for determining the eligibility of shareholders.30-07-2021
Caplin Point jumps 19%, hits record high; stock soars 37% in seven days
A combined 5.8 million equity shares, representing 7.6 per cent of the total equity of Caplin Point Laboratories, had changed hands on NSE and BSE till 12:56 pm26-07-2021